Company Cogstate Limited

Equities

CGS

AU000000CGS8

Biotechnology & Medical Research

Market Closed - Australian S.E. 01:10:10 2024-03-28 am EDT 5-day change 1st Jan Change
1.35 AUD +5.47% Intraday chart for Cogstate Limited +4.65% -6.57%

Business Summary

Cogstate Ltd is a neuroscience technology company. It is engaged in the creation, validation, and commercialization of digital brain health assessments and design and assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Research. The Clinical Trials segment includes adoption of decentralized clinical trial methodologies and scientific publication and marketing of the utility and validity of Cogstate technology. The Healthcare segment includes Cognigram, which allows for regular and standardized testing to assist in the early detection of cognitive decline that could be related to a range of factors including head injury, neurodegenerative disease or side effects following pharmacological treatments. The Research segment includes research studies and academic collaborations across various indications, such as Alzheimer's disease and Parkinson's disease.

Number of employees: 158

Sales per Business

AUD in Million2022Weight2023Weight Delta
Clinical Trials
88.3 %
56 89.7 % 53 88.3 % -4.48%
Healthcare
10.9 %
6 9.9 % 7 10.9 % +6.46%
Research
0.8 %
0 0.4 % 0 0.8 % +76.60%

Sales per region

AUD in Million2022Weight2023Weight Delta
Australia
100.0 %
62 100.0 % 60 100.0 % -3.04%

Managers

Managers TitleAgeSince
Founder - 99-12-16
Chief Executive Officer - 04-04-30
Director of Finance/CFO - 21-01-31
Chief Operating Officer - 08-12-31
Chief Tech/Sci/R&D Officer - 18-02-09
Human Resources Officer - -
General Counsel - -
Corporate Officer/Principal - 15-02-28
Corporate Officer/Principal - 19-11-18
Corporate Secretary 53 21-02-25

Members of the board

Members of the board TitleAgeSince
Chairman 65 -
Director/Board Member 57 10-08-25
Director/Board Member 50 19-08-28
Chief Executive Officer - 04-04-30
Director/Board Member - 20-11-29
Director/Board Member - 17-01-19

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 171,369,328 87,057,768 ( 50.80 %) 0 50.80 %

Shareholders

NameEquities%Valuation
Dave Dolby
15.02 %
25,732,802 15.02 % 21 M $
Myer & Myer Pty Ltd.
13.78 %
23,614,566 13.78 % 19 M $
Australian Ethical Investments Ltd. (Investment Management)
8.390 %
14,378,731 8.390 % 12 M $
11,738,243 6.850 % 10 M $
Anacacia Capital Pty Ltd.
6.083 %
10,424,974 6.083 % 8 M $
Mpyer Investments Pty Ltd.
3.537 %
6,061,872 3.537 % 5 M $
4,458,500 2.602 % 4 M $
4,438,102 2.590 % 4 M $
NAOS Asset Management Ltd.
1.846 %
3,162,897 1.846 % 3 M $
Fidelity Management & Research (Hong Kong) Ltd.
1.138 %
1,950,314 1.138 % 2 M $

Company contact information

Cogstate Ltd.

161 Collins Street Level 2

3000, Melbourne

+61 3 9664 1300

http://www.cogstate.com
address Cogstate Limited(CGS)